- Merck (Columbus, OH)
- …be tasked with the development of quality plans to implement `quality by design ` within clinical development programs, using a risk-based approach. They will ... **Operational Quality Management:** + Overseeing the strategic implementation of `quality by design ` principles in assigned clinical trials. + Develop Risk… more
- Cengage Group (Columbus, OH)
- …Expert (SME), Clinical Medical Assisting** will help to craft the design and direction of ed2go Programs. Working in partnership with product managers, ... We are bonded by our shared purpose - driving innovation that helps millions of learners improve their lives...to support B2B contacts for course evaluations and endorsements, advisor selection/support, and other community outreach. + Support the… more
- Merck (Columbus, OH)
- …translational PK/PD approaches, population pharmacokinetic models, exposure-response models, clinical trial design simulation, disease progression models, ... team in the role of Director. QP2-IO team is part of the Global Clinical Development organization and has oversight over drug development aspects related to … more
- Merck (Columbus, OH)
- …Design Control and Device Risk Management documentation for regulatory filings, clinical supply, development, design transfer qualification and post marketing ... & Development Division device functions and other personnel to ensure end-to-end Design Control principles are implemented effectively. + Participate in design … more
- Merck (Columbus, OH)
- …in the role of Senior Specialist. QP2-IO team is part of the Global Clinical Development organization and has oversight over drug development aspects related to ... clinical pharmacology and pharmacometrics of oncology drugs from post-Preclinical...or other similar programing language. + Skills in experimental design , mathematical problem solving, critical data analysis/interpretation, and statistics… more
- Merck (Columbus, OH)
- …novel quantitative approaches that seek to improve cycle time, cost/size, number of trials, clinical trial design and Go/No Go decisions + Framing critical drug ... PK/PD models, exposure response (ER) models, model-based meta-analysis (MBMA), clinical trial simulations (CTS) and disease progression modeling into programs… more
- Merck (Columbus, OH)
- …novel quantitative approaches that seek to improve cycle time, cost/size, number of trials, clinical trial design and Go/No Go decisions . Serve as a subject ... pharmacokinetics (PK) and pharmacodynamics (PD) analysis, model-based meta-analysis (MBMA), clinical trial simulations (CTS), disease progression modeling and Artificial… more